Categories: News

華盛証券獨家加碼派送《夜校》首映門票 與張天賦見面齊觀影

香港 – Media OutReach – 2023年10月1日 – 華盛証券邀你來和MC張天賦見面,一齊觀影 《夜校》 首映。

由於《夜校》首映門票有限,於10月1日00:00起,首100名首次成功完成線上開戶並存入指定金額,即可獲得MC張天賦人生首場電影《夜校》首映場戲票,先到先得。

當然,這100名客戶除獲得MC張天賦人生首場電影《夜校》首映場戲票乙張,與MC張天賦及一衆演員見面,可一齊觀首映之外,還可以獲得以下開戶活動獎賞:

(1)30日港股LV1串流行情;

(2)港股無限免傭 & 美股買賣180天免傭額度卡 &180天期權行情卡;

(3)US$25交易現金券;

(4)HK$400現金券;

(5)交易賞高達HK$1000

維持賬戶30日日均資產≥HK$10,000*加送:HK$600交易現金券;

總額加碼價值高達HK$2,000!

兩人同行開戶,完成資格登記每人加碼:額外多獲一張《夜校》首映場戲票,名額有限,送完即止。

具體點擊鏈接:https://www.vbkr.com/promo/23092711464016182

今年連獲「最優秀流行男歌手」「全球華人至尊金曲獎」的MC張天賦,被稱為「新一代歌王」,電影公司選擇與華盛証券合作送出MC張天賦人生首場電影的首映門票,也是看中了華盛証券作為香港券商的實力,據LiveReport大數據顯示,2023年9月4日-9月10日,在香港金融科技券商排名中,華盛証券沖進前三,周成交總額18.68億,成為香港人可信賴的金融科技券商。

Hashtag: #華盛証券

The issuer is solely responsible for the content of this announcement.

有關華盛資本証券有限公司

華盛証券是香港持牌券商(中央編號:AUL711),持有香港證監會授予的1、2、4、5、9號牌照,提供安全可靠的證券服務,嚴謹對待每一筆交易。華盛証券自主研發的交易平台VBrokers,提供全程線上化的港股、美股投資服務,為用戶提供流暢、高效的投資體驗。核心技術團隊自2008年建立,對開發和運營高流量的移動互聯網產品擁有豐富的經驗和深厚的科技積累。

Miscw.com

Recent Posts

Verdantis Appoints Kumar Gaurav Gupta as Chief Executive Officer

PRINCETON, N.J.--(BUSINESS WIRE)--Verdantis, a pioneering leader in AI-powered data solutions, proudly announces the appointment of…

19 mins ago

Galaxy Macau, The World-class Luxury Integrated Resort Comes to the “Experience Macao Roadshow in Jakarta”

Providing Exclusive and Unique Experiences to Indonesian Tourists MACAU SAR - Media OutReach Newswire -…

21 mins ago

SK hynix and HLDS Jointly Developed Tube T31 and Haechi H02 Win Red Dot Design Award and Exhibit at COMPUTEX

SEOUL, South Korea--(BUSINESS WIRE)--Leading semiconductor company SK hynix today announced that its stick-type SSD, the…

1 hour ago

NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+

LONDON--(BUSINESS WIRE)--NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic…

1 hour ago

Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients

GUILFORD, Conn. & SHANGHAI--(BUSINESS WIRE)--Drug Farm announced today the U.S. Food and Drug Administration (FDA)…

1 hour ago

LiveSpo Pharma Emerges as Vietnam’s Pioneer at Vitafoods Europe 2024

Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care…

2 hours ago